Related Experiment Video
Updated: May 16, 2026
08:03
Glucose Uptake Measurement and Response to Insulin Stimulation in In Vitro Cultured Human Primary Myotubes
Published on: June 25, 2017
[Glucose intolerance in myotonic dystrophy type 1].
Hiroto Takada1, Yoshinobu Oyama, Seiko Kon
1Department of Neurology, Aomori Hospital, National Hospital Organization.
Rinsho Shinkeigaku = Clinical Neurology
|December 1, 2012
Summary
Insulin resistance is common in myotonic dystrophy type 1 (DM1), affecting muscles and liver. Early intervention with metformin can improve glucose intolerance and metabolic defects in DM1 patients.
Area of Science:
- Endocrinology
- Metabolic Disorders
- Genetics
Context:
- Myotonic dystrophy type 1 (DM1) is a multisystem disorder.
- Glucose intolerance and insulin resistance are prevalent in DM1 patients.
- Metabolic complications significantly impact patient health and quality of life.
Purpose:
- To investigate the role of insulin resistance in glucose intolerance in DM1.
- To explore potential therapeutic strategies for managing metabolic defects in DM1.
- To highlight clinical considerations for managing hyperglycemia and hypoglycemia in DM1.
Summary:
- Insulin resistance, affecting both liver and muscle, is a key feature of glucose intolerance in DM1.
- Abnormal insulin secretion and low fasting plasma glucose characterize early-stage DM1 glucose intolerance.
- Metformin shows promise for improving insulin resistance, while intensive insulin therapy may be needed for severe hyperglycemia.
Impact:
- Early intervention for insulin resistance in DM1 can prevent disease progression.
- Understanding these metabolic defects aids in personalized treatment strategies.
- Clinical awareness of potential complications like hypoglycemia and dysphagia is crucial for effective patient management.
Related Concept Videos
01:27Glucose Transporters
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...